Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Ying Feng *Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.
Mariya Lobanovska *Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.ORCID 0000-0002-3513-301X
Jenna VickeryDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.
Jesse Garcia CastilloDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.
Leslie GüerecaDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.
Shannon K ChangDepartment of Plant and Microbial Biology, University of California Berkeley, Berkeley, California, USA.
Michel DuPageDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.
Daniel A PortnoyDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.ORCID 0000-0003-1218-2799
Funding
The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PORTNOY, DANIEL A · 2004 to 2025
$45.5M
Listeria Hemolysis and Escape From a VacuoleR01AI027655 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DANIEL A PORTNOY · 1993 to 2026
$10.1M
Engineering precision cancer immunotherapyDP2CA247830 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI DUPAGE, MICHEL · 2019 to 2019
$2.4M
Reversing cancer immunosuppression using attenuated Listeria monocytogenesR01CA283604 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI Michel DuPage, DANIEL A PORTNOY · 2024 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.